AbbVievsInMode

ABBV and INMD stock compared: price, dividend, valuation and results, from SEC filings.

INMD

InMode Ltd.

$13.15

Value $833M

+0.61%
INMD's page

AbbVie (ABBV) has a market value of $521B and InMode (INMD) $833M. Over the last year, with dividends, ABBV moved +30.3% and INMD -9.2%. The P/E is 50.6 for ABBV and 8.9 for INMD. Dividend yield: ABBV 2.35%, INMD none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABBV$521B

    INMD$833M

    ABBV is 625 times INMD

  • Revenue, 12 months

    ABBV$66.0B

    INMD$370M

    ABBV is 178 times INMD

  • Net income, 12 months

    ABBV$10.3B

    INMD$94M

    ABBV is 110 times INMD

  • Operating margin

    ABBV32.2%

    INMD23.1%

    9.1 points apart

  • ROIC

    ABBV25.7%

    INMD9.9%

    15.8 points apart

  • P/E

    ABBV50.6

    INMD8.9

    ABBV is 5.7 times INMD

  • Dividend yield

    ABBV2.4%

    INMD0.0%

    2.4 points apart

  • 5-year return

    ABBV+201.5%

    INMD-85.8%

    287.3 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABBV+201.5%

INMD-85.8%

010020030020222023202420252026
Returns by period
PeriodABBVWith dividendsINMDWith dividends
1 year since November 12, 2025+30.3%Price +26.5%-9.2%Price -9.2%
3 years since November 13, 2023+135.3%+33.0% a yearPrice +112.8%-33.0%-12.5% a yearPrice -33.0%
5 years since November 12, 2021+201.5%+24.7% a yearPrice +152.2%-85.8%-32.3% a yearPrice -85.8%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABBVAbbVieINMDInMode

Valuation

ABBVINMD
Valuation
Price$294.55$13.15
Market value$521B$833M
Enterprise value (EV)$591B$447M
P/E50.68.9
P/E, 5-year median57.010.3
P/B–1.2
EV/EBIT27.85.2
Free cash flow yield3.6%10.1%

Results and growth

ABBVINMD
Results and growth
Revenue, 12 months$66.0B$370M
Net income, 12 months$10.3B$94M
Free cash flow, 12 months$18.9B$84M
Earnings per share, 12 months$5.81$1.43
Revenue growth, year on year8.6%-6.2%
Revenue growth a year, past+5.9%over 5 years+12.4%over 5 years
EPS growth a year, past-2.8%over 5 years+10.0%over 5 years

Margins and returns on capital

ABBVINMD
Margins and returns on capital
Gross margin73.7%78.5%
Operating margin32.2%23.1%
Net margin15.7%25.3%
ROIC25.7%9.9%
ROE–13.7%

Balance sheet

ABBVINMD
Balance sheet
Cash$10.8B$386M
Total debt$80.9B$8.2M
Net debt / EBITDA3.2-4.5
Interest cover7.1×–

Dividends and buybacks

ABBVINMD
Dividends and buybacks
Dividend yield2.4%–
Dividend per share, 12 months$6.92–
Dividend growth a year, past+6.6%over 5 years–
Buyback yield0.2%15.3%
Shareholder yield2.5%15.3%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABBV or INMD

Didn't find what you were looking for?

Ask us
Which is bigger, AbbVie or InMode?

By market value, AbbVie ($521B) is about 625.1 times InMode ($833M), at today's prices.

How did ABBV and INMD stock do over the last 5 years?

Since November 12, 2021, ABBV's price moved +152.2% and INMD's -85.8%. With dividends: ABBV +201.5% (+24.7% a year), INMD -85.8% (-32.3% a year). Past returns do not predict future ones.

Which pays the higher dividend, ABBV or INMD?

The dividend yield at today's price is 2.35% for AbbVie and none for InMode. Over the last twelve months they paid $6.92 and – per share.

What is the P/E of ABBV and INMD?

At today's price, the P/E is 50.6 for ABBV and 8.9 for INMD. The median of the last five years was 57.0 and 10.3, which shows where each stands against its own past.

Which has the higher profit margins, AbbVie or InMode?

Over the last twelve months, the net margin was 15.7% for AbbVie and 25.3% for InMode, and the operating margin 32.2% and 23.1%. Revenue was $66.0B and $370M.

Which is the better investment, AbbVie or InMode?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.